Abstract:The innate immune response plays a crucial role in recovery from infectious diseases by promoting the clearance of pathogens. Sodium butyrate (NaB) is an energy source for cellular processes with the potential to regulate the innate immune response. The present study aimed to evaluate the effect of NaB on the innate immune response in a bovine mammary alveolar cell line (MAC-T) initiated by lipopolysaccharides (LPS). Thus, treatments were conducted as follows: treated with 1× PBS for 24 h (control), pretreated with 1 mM NaB (optimized by cell viability assays and dose-dependent experiment) for 18 h followed by treatment of 1× PBS for 6 h (NaB), pretreated with 1× PBS for 18 h followed by stimulation with LPS (1 µg/mL) for 6 h (LPS), and pretreated with 1 mM NaB for 18 h followed by stimulation with LPS (1 µg/mL) for 6 h (NaB + LPS). Different inhibitors were also used to elucidate the underlying mechanism. Furthermore, cells were treated with NaB and heat-inactivated Escherichia coli to test the effect of NaB on transcription of genes related to the innate immune response triggered by the major causative pathogen of mastitis. Each treatment had 3 replicates and was repeated 3 times. Proinflammatory cytokines, chemokines, and β-defensins are crucial secretion factors in innate immunity, and transcription of these factors was increased by NaB during challenge with LPS or heat-inactivated E. coli in MAC-T cells. Acetylation of histone H3 protein, which promotes gene expression by affecting the structure of chromatin, was also upregulated by NaB in response to LPS stimulation. P38 mitogen-activated protein kinases (MAPK), JNK, and Erk 1 and 2 are key upstream regulators of the expression of proinflammatory cytokines, chemokines, and β-defensins, and their activity was enhanced by NaB during LPS stimulation. Furthermore, inhibitors were used to assess the role of MAPK signaling in the effects of NaB. The results showed that inhibitors of p38 MAPK, Erk, and JNK attenuated the NaB-induced upregulation of TNF and β-defensin 5 (DEFB5) transcription, and that the inhibitor of Erk attenuated the NaB-induced upregulation of IL1B transcription during LPS challenge. Enhanced transcription of CXCL8 by NaB was blocked by the inhibitor of Erk and p38 MAPK during LPS stimulation. Overall, NaB boosted the LPS-induced innate immune response by promoting the expression of proinflammatory cytokines, chemokines, and β-defensins, which was associated with enhanced MAPK signaling activation and histone H3 acetylation.

Sodium Butyrate Inhibits Interferon-Gamma Induced Indoleamine 2,3-Dioxygenase Expression Via STAT1 in Nasopharyngeal Carcinoma Cells.

Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels.

Sodium Butyrate Inhibits Migration and Induces AMPK-mTOR Pathway-Dependent Autophagy and ROS-mediated Apoptosis Via the Mir-139-5p/bmi-1 Axis in Human Bladder Cancer Cells.

Sodium Butyrate Upregulates Expression of NKG2D Ligand MICA/B in HeLa and HepG2 Cell Lines and Increases Their Susceptibility to NK Lysis

Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation

Expression of Indoleamine 2,3-Dioxygenase in Nasopharyngeal Carcinoma Impairs the Cytolytic Function of Peripheral Blood Lymphocytes

[Influence of Sodium Butyrate on Growth of HT-29 Colon Carcinoma Cells and Expression of Inducible Nitric Oxide Synthase (Inos)].

IFN-β Pretreatment Alleviates Allogeneic Renal Tubular Epithelial Cell-Induced NK Cell Responses via the IRF7/HLA-E/NKG2A Axis.

Sodium butyrate prevents cytokine-induced β-cell dysfunction through restoration of stromal interaction molecule 1 expression and activation of store-operated calcium entry

Inhibition of Store-Operated Ca2+ Entry Counteracts the Apoptosis of Nasopharyngeal Carcinoma Cells Induced by Sodium Butyrate.

Sodium Butyrate Ameliorates Deoxynivalenol-Induced Oxidative Stress and Inflammation in the Porcine Liver Via NR4A2-Mediated Histone Acetylation.

Sodium butyrate suppresses NOD1‐mediated inflammatory molecules expressed in bovine hepatocytes during iE‐DAP and LPS treatment

Sodium Butyrate Induces Autophagic Apoptosis of Nasopharyngeal Carcinoma Cells by Inhibiting AKT/mTOR Signaling.

Sodium Butyrate Abrogates the Growth and Pathogenesis of <i>Mycobacterium bovis</i> via Regulation of Cathelicidin (LL37) Expression and NF-B Signaling

Sodium Butyrate Promotes Lipopolysaccharide-Induced Innate Immune Responses by Enhancing Mitogen-Activated Protein Kinase Activation and Histone Acetylation in Bovine Mammary Epithelial Cells

The Effects of Sodium Butyrate on Transcription Are Mediated Through Activation of A Protein Phosphatase

Sodium Butyrate Reduces High-Fat Diet-Induced Non-Alcoholic Steatohepatitis Through Upregulation of Hepatic GLP-1R Expression

Interferon-alpha Promotes Immunosuppression Through IFNAR1/STAT1 Signalling in Head and Neck Squamous Cell Carcinoma.

Signaling Pathways Inducing Expression of Idoleamine 2,3-Dioxygenase

Sodium butyrate blocks the growth of colorectal cancer by inhibiting the aerobic glycolysis mediated by SIRT4/HIF-1α

Sodium butyrate induces senescence and inhibits the invasiveness of glioblastoma cells